CR Sanjiu's registered capital increased to approximately 1.66 billion yuan

36Kr learned that the Aiqicha App shows that recently, CR Sanjiu Pharmaceutical Co., Ltd. underwent a business change, with its registered capital increasing from approximately RMB 1.28 billion to approximately RMB 1.66 billion, an increase of about 30%. CR Sanjiu Pharmaceutical Co., Ltd. was established in April 1999, with Wu Wendo as the legal representative. Its business scope includes the planting of traditional Chinese medicinal materials, the import of machinery and raw materials needed for production, and the export of self-produced products, among others, and is jointly held by China Resources Pharmaceutical Group Limited, China Chengtong Holdings Group Limited, Hong Kong Securities Clearing Company Limited, and others